Your doctor will determine the best dosage to suit your needs. intravenous (IV) infusion (an injection into a vein that’s given over time), which lasts about 30 minutes liquid solution given by ...

The western North Carolina plant that makes 60 percent of the country's intravenous fluid supply has restarted its ... supply ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

The drug is usually given as an injection under your skin. But for UC, a healthcare professional will give you the first few doses as an intravenous (IV) infusion (an injection into your vein over ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced today. Along ...

Federal regulators have approved a change to the expiration dates for multiple types of intravenous (IV) and sterile fluids made at a key manufacturing plant recovering from the impact of ...

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

The North Cove–based manufacturing plant of Baxter International — the largest supplier of intravenous (IV) and peritoneal ... and sterile water for injection allocations, with additional ...

North Carolina hospitals reeling from Hurricane Helene may soon get some relief from a critical IV fluid shortage ... date on multiple types of intravenous and sterile fluids made by Baxter ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...